Baudax Bio Inc
Change company Symbol lookup
Select an option...
BXRX Baudax Bio Inc
ZM Zoom Video Communications Inc
CIOXY Cielo SA
T AT&T Inc
PBCT People's United Financial Inc
PHK PIMCO High Income Fund
BAC Bank of America Corp
BHF Brighthouse Financial Inc
CTBI Community Trust Bancorp Inc
$NYLGCAPT NYSE U.S. Large Cap Equal Weight Ind
Go

Company profile

Baudax Bio, Inc. is a specialty pharmaceutical company focused on developing and commercializing products for acute care settings. The Company’s lead product candidate is IV injectable form of Meloxicam, a long-acting preferential cyclooxygenase (COX)-2 inhibitor. The Company’s product pipeline also includes other early-stage product candidates, including two neuromuscular blocker agents (NMBAs) and a related chemical reversal agent, and Dexmedetomidine (Dex)- intranasal (IN), an intranasal formulation of dexmedetomidine. The Company is developing an intermediate-acting NMBA, RP100; an ultrashort-acting NMBA, RP2000, and a reversal agent specific to its NMBAs.

Price
Delayed
$3.74
Day's Change
0.05 (1.36%)
Bid
--
Ask
--
B/A Size
--
Day's High
3.78
Day's Low
3.69
Volume
(Light)

Today's volume of 145,741 shares is on pace to be much lighter than BXRX's 10-day average volume of 982,021 shares.

145,741

UPDATE: Coronavirus isn't stopping the rich from getting even richer on Wall Street

4:00 pm ET March 26, 2020 (MarketWatch)
Print

By Mark Hulbert, MarketWatch

America's 'winner take all' economy is alive and well

Since the U.S. stock market peaked on Feb. 19, the five stocks with the largest market caps have nonetheless beaten the market.

I'm referring to Apple (AAPL) , Microsoft (MSFT) , Amazon.com (AMZN) , Alphabet (GOOGL) and Facebook (FB) . Since the market's high, these stocks are down an average of 22.9%, according to Factset, versus a 26.6% loss for the S&P 500 and a 27.5% loss for the Dow Jones Industrial Average . (Returns through Mar. 25.)

These largest stocks' relative strength has surprised some observers, who had expected that these stocks, which had dominated the bull market on the way up, would be among the biggest losers on the way down.

But a new study suggests that, far from indicating the stock market has become top-heavy and overvalued, the dominance of the largest stocks is a symptom of a much more profound and longer-term shift: The stock market is becoming split between a few large firms that are wildly profitable and everything else.

Authored by Hendrik Bessembinder, a finance professor at Arizona State University, the study is entitled "Wealth Creation in the U.S. Public Markets 1926 to 2019 (https://ssrn.com/abstract=3537838)." In it, he updates his previous research that had analyzed data through 2016.

Consider, for example, how definitively these same five mega-cap stocks dominated the bull market that just came to an end. Bessembinder reports that, over the three calendar years through 2019, these five stocks accounted for an incredible 22.1% of the total wealth created by the entire stock market.

This concentration of wealth creation creates big challenges for those trying to create diversified stock portfolios. Consider that in Bessembinder's database there were 4,896 publicly traded stocks in the three-year period ending December 2019. Notice that you could have constructed an index fund out of all but five of those stocks -- 4,891 in all -- and still trailed the market by 22.1% if those five missing stocks were Apple, Microsoft, Amazon, Alphabet and Facebook.

That's amazing, because you'd otherwise have been confident that a portfolio containing more than 4,000 issues, constituting 99.9% of all publicly-traded stocks, was more than adequately diversified.

Here's another way in which Bessembinder makes the same point: How many companies are needed to account for 50% of the total wealth creation over the trailing three years? The answer for the three years ending this past December is just 48 out of the total of 4,896 -- or 0.98%. This is one of the lowest percentages of any three-year periods since the 1920s, as you can see from the chart below.

To put that in perspective, consider inequality of wealth in the U.S. -- a topic that has received enormous attention in the Democratic primaries. According to the Brookings Institution (https://www.brookings.edu/blog/up-front/2019/06/25/six-facts-about-wealth-in-the-united-states/), the top 1% of Americans own 29% of the total wealth in the U.S. Skewed as that is, wealth inequality is nearly double that in the stock market, where the top 1% account for 50% of total wealth creation.

What's happening in the stock market is yet more evidence that the U.S. is moving towards a "winner take all" economy. I'm referring to a prediction made in 2005 in the Journal of Economics & Management Strategy (https://ssrn.com/abstract=250371) by Thomas Noe of Oxford University and Geoffrey Parker of Dartmouth. The researchers predicted that, because of so-called "network" effects in an internet-based economy, industries will become increasingly dominated by their largest companies. In an interview, Bessembinder told me that his results clearly are consistent with Noe's and Parker's prediction.

The investment implication of this new research is that diversification is more important than ever. Unless you're confident that your portfolio owns each of the stocks that will be the top performers in coming years, you should seriously consider putting your money in a broad market index fund.

Mark Hulbert is a regular contributor to MarketWatch. His Hulbert Ratings tracks investment newsletters that pay a flat fee to be audited. He can be reached at mark@hulbertratings.com (mailto:mark@hulbertratings.com)

Read: These are the 20 stocks corporate insiders have been buying most amid the coronavirus-induced market selloff (http://www.marketwatch.com/story/these-are-the-20-stocks-corporate-insiders-have-been-buying-most-amid-the-coronavirus-induced-market-selloff-2020-03-25)

More: That coronavirus stimulus deal? Don't exaggerate the effect of the 2008 bailouts on the stock market (http://www.marketwatch.com/story/dont-exaggerate-the-effect-of-the-2008-stimulus-programs-on-the-stock-market-2020-03-26)

-Mark Hulbert; 415-439-6400; AskNewswires@dowjones.com

(END) Dow Jones Newswires

March 26, 2020 16:00 ET (20:00 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.